Consistent with the results of immunofluorescence staining, Western blotting showed a significant decrease in the expression of the synthetic VSMC marker OPN and the cell proliferation marker Ki67 in the O304-treated group compared with the AAA group (Figures 5H–J; Supplementary Figure S7). The gene discussed is MKI67; the disease is triple-A syndrome.